USC research helps stem cell experts develop kidney treatments, reduce dialysis

USC News highlighted work by Carl Kesselman and his team, who created DERIVA (Discovery Environment for Relational Information and Versioned Assets), a software program that collects data from microscopes and organizes it and other data into virtual photo albums that easily can be shared with other researchers. Their work is part of a three-study series published on Feb. 15 in the Journal of the American Society of Nephrology. (February 15, 2018)

USC, Agilent Technologies to open center

Daily Trojan reports that Agilent Technologies announced a new collaboration with the USC Michelson Center for Convergent Bioscience to develop an Agilent Center of Excellence in Biomolecular Characterization. The Agilent CoE, which will be housed in Michelson Hall, will provide students and local customers with access to scientific researchers, Agilent instrumentation and technologies all in one scientific environment. (January 30, 2018)

‘An unprecedented year of new buildings’ at USC

USC News looks back on the year in construction at USC, highlighting the USC Village and Michelson Hall, home of the USC Michelson Center for Convergent Bioscience, as two projects that “will leave lasting impacts on future generations of Trojans and scientific research.” (December 26, 2017)

How a tumor grows can predict response to cancer therapy

USC Viterbi News writes about a new study out of the USC Viterbi School of Engineering that finds tumor growth properties can influence response to cancer drugs. “Identifying a measurement or quantity that predicts how specific tumors will respond, called a predictive biomarker, is extremely valuable to cancer research,” said Stacey Finley, a USC assistant professor of Biomedical Engineering, co-author to the study, the Gordon S. Marshall Early Career Chair, and a faculty member at the USC Michelson Center for Convergent Bioscience. (December 21, 2017)

Michelson Center researchers advance work on nonaddictive opioid painkiller

USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)

Viterbi Researchers Design Thermal ‘Skin’ to Maintain Temperature of Satellites

USC Viterbi writes that a team of USC researchers that developed a new material to self-regulate the temperature of a satellite, working in conjunction with a team at Northrop Grumman, will benefit from “the new capabilities in the recently-dedicated John D. O’Brien Nanofabrication Laboratory in the USC Michelson Center for Convergent Bioscience.”